Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 99 entries
View as:

Bioequivalency Study of Terbinafine Tablets Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT00602342 Org: User:
Start: 03/31/04 End: 04/30/04 Due: 04/30/05

Bioequivalency Study of 450 mg Lithium Carbonate Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT00602381 Org: User:
Start: 11/30/02 End: 11/30/02 Due: 11/30/03

Clinical Endpoint Bioequivalence Study for Fluticasone Propionate and Salmeterol Xinafoate

Phase: N/A Priority: Normal
NCT ID: NCT02649478 Org: User:
Start: 08/31/14 End: 11/30/15 Due: 11/30/16

Bioequivalency Study of Naratriptan Hydrochloride 2.5 mg Under Fed Conditions

Phase: N/A Priority: Normal
NCT ID: NCT01161654 Org: User:
Start: 08/31/07 End: 09/30/07 Due: 09/30/08

Crossover Bioequivalence Study of Irbesartan 300 mg Tablets Under Fed Conditions

Phase: N/A Priority: Normal
NCT ID: NCT01712100 Org: User:
Start: 08/31/07 End: 08/31/07 Due: 08/31/08

Bioequivalency Study of Mycophenolate Mofetil 250 mg Capsules Under Fasted Conditions

Phase: N/A Priority: Normal
NCT ID: NCT00893542 Org: User:
Start: 11/30/05 End: 11/30/05 Due: 11/30/06

Bioequivalency Study of Imipramine Pamoate 75 mg Capsules Under Fasted Conditions

Phase: N/A Priority: Normal
NCT ID: NCT01107353 Org: User:
Start: 08/31/08 End: 09/30/08 Due: 09/30/09

Bioequivalency Study of Losartan Potassium/Hydrochlorothiazide 100 mg /25 mg Tablet Under Fed Conditions

Phase: N/A Priority: Normal
NCT ID: NCT01102465 Org: User:
Start: 02/28/05 End: 03/31/05 Due: 03/31/06

Pilot Bioequivalency Study of Exemestane 25 mg Tablet Under Fasted Conditions

Phase: N/A Priority: Normal
NCT ID: NCT01331447 Org: User:
Start: 05/31/04 End: 05/31/04 Due: 05/31/05

Safety and Pharmacokinetic Study of Oral Morphine Sulfate in Pediatric Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01322360 Org: User:
Start: 04/30/11 End: 04/30/12 Due: 04/30/13

Bioequivalency Study of Montelukast Chewable 5 mg Tablets Under Fed Conditions

Phase: N/A Priority: Normal
NCT ID: NCT01659892 Org: User:
Start: 08/31/08 End: 08/31/08 Due: 08/31/09

Bioequivalency Study of Torsemide Tablets Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT00602303 Org: User:
Start: 09/30/03 End: 09/30/03 Due: 09/30/04

Bioequivalency Study of Levetiracetam 750 mg Tablets Under Fed Conditions

Phase: N/A Priority: Normal
NCT ID: NCT00826787 Org: User:
Start: 08/31/05 End: 08/31/05 Due: 08/31/06

Bioequivalency Study of Montelukast 10 mg Tablets Under Fed Conditions

Phase: N/A Priority: Normal
NCT ID: NCT01659918 Org: User:
Start: 02/29/08 End: 02/29/08 Due: 02/28/09

A Single-Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Ropinirole 0.25 mg Tablets Under Fed Conditions

Phase: N/A Priority: Normal
NCT ID: NCT00674310 Org: User:
Start: 02/29/04 End: 02/29/04 Due: 02/28/05

Bioequivalency Study of 300 mg Lithium Carbonate Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT00601536 Org: User:
Start: 04/30/03 End: 05/31/03 Due: 05/31/04

Bioequivalency Study of 50 mg Cilostazol Tablets Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT00602407 Org: User:
Start: 02/29/04 End: 03/31/04 Due: 03/31/05

Bioequivalency Study of Sertraline Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT00602849 Org: User:
Start: 06/30/03 End: 07/31/03 Due: 07/31/04

Bioequivalency Study of Oxcarbazepine 600 mg Tablets Under Fed Conditions

Phase: N/A Priority: Normal
NCT ID: NCT00618046 Org: User:
Start: 11/30/04 End: 11/30/04 Due: 11/30/05

Bioequivalency Study of Letrozole 2.5 mg Tablets Under Fed Conditions

Phase: N/A Priority: Normal
NCT ID: NCT01367626 Org: User:
Start: 03/31/08 End: 04/30/08 Due: 04/30/09

Bioequivalency Study of Levetiracetam 1g Tablets Under Fed Conditions

Phase: N/A Priority: Normal
NCT ID: NCT00827320 Org: User:
Start: 06/30/07 End: 06/30/07 Due: 06/30/08

Bioequivalency Study of Torsemide Tablets Under Fed Conditions

Phase: N/A Priority: Normal
NCT ID: NCT00602615 Org: User:
Start: 09/30/03 End: 09/30/03 Due: 09/30/04

Crossover Bioequivalence Study of Irbesartan HCTZ 300/25 mg Tablets Under Fasted Conditions

Phase: N/A Priority: Normal
NCT ID: NCT01712139 Org: User:
Start: 09/30/07 End: 09/30/07 Due: 09/30/08

Bioequivalency Study of Anastrozole 1 mg Under Fasted Conditions

Phase: N/A Priority: Normal
NCT ID: NCT01155102 Org: User:
Start: 04/30/06 End: 05/31/06 Due: 05/31/07

Bioequivalency Study of Losartan Potassium 100 mg Tablet Under Fed Conditions

Phase: N/A Priority: Normal
NCT ID: NCT01216878 Org: User:
Start: 09/30/04 End: 09/30/04 Due: 09/30/05